Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Int J Mol Sci ; 22(17)2021 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-34502400

RESUMEN

Giardiasis represents a latent problem in public health due to the exceptionally pathogenic strategies of the parasite Giardia lamblia for evading the human immune system. Strains resistant to first-line drugs are also a challenge. Therefore, new antigiardial therapies are urgently needed. Here, we tested giardial arginine deiminase (GlADI) as a target against giardiasis. GlADI belongs to an essential pathway in Giardia for the synthesis of ATP, which is absent in humans. In silico docking with six thiol-reactive compounds was performed; four of which are approved drugs for humans. Recombinant GlADI was used in enzyme inhibition assays, and computational in silico predictions and spectroscopic studies were applied to follow the enzyme's structural disturbance and identify possible effective drugs. Inhibition by modification of cysteines was corroborated using Ellman's method. The efficacy of these drugs on parasite viability was assayed on Giardia trophozoites, along with the inhibition of the endogenous GlADI. The most potent drug against GlADI was assayed on Giardia encystment. The tested drugs inhibited the recombinant GlADI by modifying its cysteines and, potentially, by altering its 3D structure. Only rabeprazole and omeprazole decreased trophozoite survival by inhibiting endogenous GlADI, while rabeprazole also decreased the Giardia encystment rate. These findings demonstrate the potential of GlADI as a target against giardiasis.


Asunto(s)
Giardia lamblia/efectos de los fármacos , Giardiasis/tratamiento farmacológico , Hidrolasas/metabolismo , Animales , Antiprotozoarios/farmacología , Simulación por Computador , Cisteína/química , Evaluación Preclínica de Medicamentos/métodos , Reposicionamiento de Medicamentos/métodos , Giardia lamblia/patogenicidad , Giardiasis/inmunología , Tiomalato Sódico de Oro/farmacología , Humanos , Hidrolasas/efectos de los fármacos , Hidrolasas/ultraestructura , Omeprazol/farmacología , Inhibidores de la Bomba de Protones/farmacología , Rabeprazol , Tiamina/análogos & derivados , Tiamina/farmacología , Trofozoítos/efectos de los fármacos
2.
Microb Pathog ; 114: 95-98, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29180294

RESUMEN

Bovine neonatal diarrhea is common due low immunity in newborn calves, poor management (or absence) of sanitary barriers, and other factors. Newborn calves with diarrhea in the first days of life suffer failure to thrive and may die if left untreated. The aim of this study was to evaluate whether prophylactic administration of a homeopathic product (Dia 100®) can control bovine neonatal diarrhea in calves born on a farm with substantial sanitary challenges. We counted total bacteria and protozoan parasites in fecal samples. We measured serum glucose, total protein, globulin, albumin, cholesterol and triglycerides on days 1, 7 and 14 of life. Twenty newborn calves were maintained in individual stalls, and were divided in two groups: ten untreated animals (control) and ten animals treated with Dia 100®. Fecal consistency was evaluated daily. We diagnosed diarrhea in five animals in the treated group, and in all animals from the control group. Infections with Escherichia coli and Giardia duodenalis were identified as the responsible organisms. The E. coli count was low in the treatment group on day 7 of life compared with the control group. Antibiotics were given to eight animals in the control group, and to two animals in the treatment group. On day of life 7, serum levels of total protein and globulins were higher in the control group, but were lower on day 14. Serum levels of glucose and triglycerides were greater in treated animals on days 7 and 14, suggesting that the homeopathic product contributes to improvement of intestinal health and absorption and nutrients. We conclude that Dia 100® controls diarrhea with 50% of efficacy, and reduces antibiotic utilization.


Asunto(s)
Infecciones Bacterianas/microbiología , Infecciones Bacterianas/veterinaria , Enfermedades de los Bovinos/tratamiento farmacológico , Enfermedades de los Bovinos/prevención & control , Diarrea/tratamiento farmacológico , Diarrea/prevención & control , Diarrea/veterinaria , Animales , Animales Recién Nacidos , Antibacterianos/uso terapéutico , Glucemia/análisis , Proteínas Sanguíneas/análisis , Brasil , Bovinos , Enfermedades de los Bovinos/microbiología , Colesterol/sangre , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Infecciones por Escherichia coli/veterinaria , Heces/microbiología , Heces/parasitología , Giardia lamblia/aislamiento & purificación , Giardia lamblia/patogenicidad , Giardiasis/tratamiento farmacológico , Giardiasis/parasitología , Giardiasis/prevención & control , Giardiasis/veterinaria , Intestinos , Infecciones por Protozoos/tratamiento farmacológico , Infecciones por Protozoos/parasitología , Infecciones por Protozoos/prevención & control , Albúmina Sérica/análisis , Seroglobulinas/análisis , Factores de Tiempo , Triglicéridos/sangre
3.
Acta Trop ; 156: 48-56, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26772449

RESUMEN

A randomised, double-blind, placebo-controlled trial was carried out among Mexico children aged 6-15 months to determine how household characteristics modify vitamin A and zinc supplementation efficacy on Ascaris lumbricoides, Giardia intestinalis and Entamoeba histolytica/E. dispar infection durations. Children assigned to receive vitamin A every 2 months, a daily zinc supplement, a combined vitamin A-zinc supplement or a placebo were followed for 1 year. Parametric hazard models were fit to infection durations stratified by personal and household factors. Children supplemented with vitamin A and zinc combined from households lacking piped water and children in all three treatment arms from households with dirt floors had longer G. intestinalis and A. lumbricoides infection durations than their counterparts, respectively. Shorter E. histolytica/E.dispar durations were found among zinc-supplemented children of mothers who had <6 years of education and no indoor bathrooms. Heterogeneity in supplementation efficacy among children may reflect differences in exposure risk and baseline immune responses.


Asunto(s)
Suplementos Dietéticos , Parasitosis Intestinales/tratamiento farmacológico , Vitamina A/administración & dosificación , Vitaminas/administración & dosificación , Zinc/administración & dosificación , Animales , Ascariasis/tratamiento farmacológico , Ascaris lumbricoides/patogenicidad , Método Doble Ciego , Composición Familiar , Heces/parasitología , Femenino , Giardia lamblia/patogenicidad , Giardiasis/tratamiento farmacológico , Vivienda/normas , Humanos , Lactante , Masculino , México , Recuento de Huevos de Parásitos , Padres/educación , Estudios Prospectivos
4.
PLoS One ; 7(9): e45325, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23028934

RESUMEN

In the field of infectious diseases the multifaceted amino acid arginine has reached special attention as substrate for the hosts production of the antimicrobial agent nitric oxide (NO). A variety of infectious organisms interfere with this part of the host immune response by reducing the availability of arginine. This prompted us to further investigate additional roles of arginine during pathogen infections. As a model we used the intestinal parasite Giardia intestinalis that actively consumes arginine as main energy source and secretes an arginine-consuming enzyme, arginine deiminase (ADI). Reduced intestinal epithelial cell (IEC) proliferation is a common theme during bacterial and viral intestinal infections, but it has never been connected to arginine-consumption. Our specific question was thereby, whether the arginine-consumption by Giardia leads to reduced IEC proliferation, in addition to NO reduction. In vitro cultivation of human IEC lines in arginine-free or arginine/citrulline-complemented medium, as well as in interaction with different G. intestinalis isolates, were used to study effects on host cell replication by MTT assay. IEC proliferation was further analyzed by DNA content analysis, polyamine measurements and expressional analysis of cell cycle regulatory genes. IEC proliferation was reduced upon arginine-withdrawal and also in an arginine-dependent manner upon interaction with G. intestinalis or addition of Giardia ADI. We show that arginine-withdrawal by intestinal pathogens leads to a halt in the cell cycle in IECs through reduced polyamine levels and upregulated cell cycle inhibitory genes. This is of importance with regards to intestinal tissue homeostasis that is affected through reduced cell proliferation. Thus, the slower epithelial cell turnover helps the pathogen to maintain a more stable niche for colonization. This study also shows why supplementation therapy of diarrhea patients with arginine/citrulline is helpful and that citrulline especially should gain further attention in future treatment strategies.


Asunto(s)
Arginina/metabolismo , Células Epiteliales/parasitología , Giardia lamblia/metabolismo , Giardia lamblia/patogenicidad , Intestinos/citología , Células CACO-2 , Ciclo Celular/fisiología , Proliferación Celular , Humanos , Hidrolasas/metabolismo , Ornitina Carbamoiltransferasa/metabolismo , Poliaminas/metabolismo
5.
Antonie Van Leeuwenhoek ; 102(1): 61-72, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22382675

RESUMEN

The present study describes the in vivo ameliorating effect of Lactobacillus casei supplementation in renourished Giardia intestinalis infected BALB/c mice. It was observed that daily administration of probiotic 7 days prior to Giardia-infection to renourished mice, efficiently reduced the excretion of Giardia cysts and trophozoite counts, along with significant increased fecal lactobacilli counts compared with Giardia-infected mice. It was also observed that oral feeding of probiotic to renourished-Giardia-infected mice abrogated all the anthropometric and biochemical anomalies. Histologically, morphological and cellular alteration of microvillus membrane integrity revealed that probiotic administration further ameliorated the mucosal damage in renourished-probiotic-Giardia-infected mice compared to severe microvillus atrophy, oedematous, vacuolated epithelial cells and ileitis in renourished-Giardia and Giardia-infected mice. Thus, it is suggested that probiotic used as the functional food helps in restoration of anthropometric, biochemical alterations and atrophied gut by enhancing the goblet cells and reducing the giardiasis.


Asunto(s)
Dieta/métodos , Giardia lamblia/patogenicidad , Giardiasis/patología , Lacticaseibacillus casei/crecimiento & desarrollo , Probióticos/administración & dosificación , Animales , Biometría , Suplementos Dietéticos , Mucosa Intestinal/patología , Ratones , Ratones Endogámicos BALB C , Microvellosidades/patología
6.
Nutr. hosp ; 26(4): 922-925, jul.-ago. 2011.
Artículo en Español | IBECS | ID: ibc-111172

RESUMEN

El adenocarcinoma gástrico es una de las causas más frecuentes de mortalidad en el mundo, siendo la cirugía el único tratamiento potencialmente curativo, aunque los efectos adversos digestivos y nutricionales son frecuentes y abundantes. La hipogammaglobulinemia variable comunes causa de frecuentes manifestaciones digestivas, derivándose las más importantes en diarrea crónica causada porgiardiasis, hiperplasia nodular linfoide o atrofia vellosa, siendo frecuente la mal absorción y la desnutrición. Los déficits nutricionales secundarios a la mal absorción (postgastrectomía y asociada a la atrofia vellosa y la giardiasis por hipogammaglobulinemia variable común) son asi mismo frecuentes. Presentamos el caso de un paciente gastrectomizado por adenocarcinoma gástrico y con hipogammaglobulinemia variable común e infestación crónica por giardiasis que presenta una importante diarrea crónica refractaria a tratamiento y mal absorción (AU)


Gastric cancer is a frequent cause of cancer-related mortality in the world. Surgery is the only potentially curative therapy, although the adverse effects of surgery are common and considerable. Common variable immunodeficiency is in many cases cause of gastro intestinal system problems such as chronic diarrhea caused by infestation with giardia lamblia, nodular lymphoid hiperplasia ad loss of villi leading frequently to malapsortion and malnutrition. Nutritional deficiencies due to malapsorption (postgastrectomy and secondary to loss of villi, giardiasis andc ommon variable immunodeficiency ) are common. We present the case of a patient with gastric cancer who underwent a gastrectomy with common variable hipogammaglobulinemia and chronic infestation by giardia lamblia, with serious diarrhea resistant to treatment and malabsorption (AU)


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Terapia Nutricional/métodos , Diarrea/dietoterapia , Giardiasis/tratamiento farmacológico , Gastrectomía , Neoplasias Gástricas/cirugía , Agammaglobulinemia/complicaciones , Giardia lamblia/patogenicidad , Síndromes de Malabsorción/dietoterapia , Complicaciones Posoperatorias
7.
PLoS Negl Trop Dis ; 5(6): e1158, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21666789

RESUMEN

BACKGROUND: Asymptomatic carriage of Giardia intestinalis is highly prevalent among children in developing countries, and evidence regarding its role as a diarrhea-causing agent in these settings is controversial. Impaired linear growth and cognition have been associated with giardiasis, presumably mediated by malabsorption of nutrients. In a prospective cohort study, we aim to compare diarrhea rates in pre-school children with and without Giardia infection. Because the study was conducted in the context of an intervention trial assessing the effects of multi-nutrients on morbidity, we also assessed how supplementation influenced the relationship between Giardia and diarrhoea rates, and to what extent Giardia modifies the intervention effect on nutritional status. METHODS AND FINDINGS: Data were collected in the context of a randomized placebo-controlled efficacy trial with 2×2 factorial design assessing the effects of zinc and/or multi-micronutrients on morbidity (n=612; height-for-age z-score <-1.5 SD). Outcomes measures were episodes of diarrhea (any reported, or with ≥3 stools in the last 24 h) and fever without localizing signs, as detected with health-facility based surveillance. Giardia was detected in stool by enzyme-linked immunosorbent assay. Among children who did not receive multi-nutrients, asymptomatic Giardia infection at baseline was associated with a substantial reduction in the rate of diarrhea (HR 0.32; 0.15-0.66) and fever without localizing signs (HR 0.56; 0.36-0.87), whereas no such effect was observed among children who received multi-nutrients (p-values for interaction 0.03 for both outcomes). This interaction was independent of age, HAZ-scores and distance to the research dispensary. There was no evidence that Giardia modified the intervention effect on nutritional status. CONCLUSION: Although causality of the Giardia-associated reduction in morbidity cannot be established, multi-nutrient supplementation results in a loss of this protection and thus seems to influence the proliferation or virulence of Giardia or associated intestinal pathogens.


Asunto(s)
Portador Sano/terapia , Diarrea/prevención & control , Dietoterapia/efectos adversos , Dietoterapia/métodos , Alimentos/efectos adversos , Giardia lamblia/aislamiento & purificación , Giardiasis/terapia , Preescolar , Estudios de Cohortes , Heces/parasitología , Femenino , Fiebre/prevención & control , Giardia lamblia/patogenicidad , Humanos , Lactante , Masculino , Placebos/administración & dosificación , Estudios Prospectivos , Tanzanía , Resultado del Tratamiento , Virulencia
8.
Parasitol Res ; 97(5): 399-407, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16151735

RESUMEN

Giardia lamblia is the causative agent of giardiasis, a common parasitic infection of the human and animal digestive tract. Although several drugs have been available to treat this infection, they present unpleasant side effects or cytotoxicity. In order to find a more natural treatment for the disease, we analyzed the effects of the methanolic extract and three fractions obtained from Hovenia dulcis Thunb. (Rhamnaceae) leaves on G. lamblia. Comparing all fractions, dichloromethane was more efficient in reducing Giardia growth. The exposition of G. lamblia to this fraction lead to degenerations in the surface, modifications in the cell shape and alterations in the localization of nuclei. Besides that, the adhesion of G. lamblia was also altered. Experiments revealed that the obtained fraction did not present cytotoxic effects in mammalian cells. In summary, dichloromethane fraction has strong antigiardial effects and could become an important new substance for the treatment of giardiasis.


Asunto(s)
Giardia lamblia/efectos de los fármacos , Extractos Vegetales/farmacología , Rhamnaceae/química , Animales , Línea Celular , Células Epiteliales/parasitología , Giardia lamblia/crecimiento & desarrollo , Giardia lamblia/patogenicidad , Humanos , Intestinos/citología , Intestinos/parasitología , Cloruro de Metileno/química , Pruebas de Sensibilidad Parasitaria , Extractos Vegetales/química , Extractos Vegetales/toxicidad , Hojas de la Planta/química , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA